An 81-Year-Old Geriatric Patient with Metastatic Pancreatic Cancer Demonstrating Excellent Response and Well Tolerance to NALIRIFOX: A Case Report and Literature Review

An 81-Year-Old Geriatric Patient with Metastatic Pancreatic Cancer Demonstrating Excellent Response and Well Tolerance to NALIRIFOX: A Case Report and Literature Review

<b>Background and Clinical Significance:</b> Pancreatic cancer was the third leading cause of cancer-related mortality in the United States in 2020 after lung and colorectal cancers. The prevalence of pancreatic cancer has been increasing and is projected to continue rising through 2040,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bayan Khasawneh, Abdullah Esmail, Ebtesam Al-Najjar, Seif El Beheary, Maen Abdelrahim
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Series:	Reports
Subjects:	pancreatic cancer NALIRIFOX PDAC toxicity and tolerability
Online Access:	https://www.mdpi.com/2571-841X/8/2/69
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cost-effectiveness of NALIRIFOX versus Nab-paclitaxel and gemcitabine in previously untreated metastatic pancreatic ductal adenocarcinoma
by: Wenjie Liu, et al.
Published: (2025-04-01)

Correlative Analysis of Tumor-Informed Circulating Tumor DNA (ctDNA) and the Survival Outcomes of Patients with Pancreatic Adenocarcinoma
by: Yuqi Zhang, et al.
Published: (2025-05-01)

Cost-effectiveness analysis of first-line combination chemotherapy regimens for metastatic pancreatic cancer and evidence-based pricing strategy of liposomal irinotecan in China
by: Zuojuan Xiang, et al.
Published: (2024-12-01)

Prolonged Survival Outcome in a Patient with Refractory Metastatic Colorectal Cancer Treated with Regorafenib Plus 5-Fluorouracil: A Case Report and Literature Review
by: Abdullah Esmail, et al.
Published: (2025-04-01)

Idiopathic Duodenal Hematoma: A Case Report and Literature Review
by: Ebtesam Al-Najjar, et al.
Published: (2025-05-01)

Safety and Efficacy of Regorafenib and 5-Fluorouracil Combination Therapy in Refractory Metastatic Colorectal Cancer After Third-Line Treatment: An Institutional Experience
by: Maen Abdelrahim, et al.
Published: (2025-05-01)

18F−Prostate−Specific Membrane Antigen PET/CT imaging for potentially resectable pancreatic cancer (PANSCAN−2): a phase I/II study
by: Jisce R. Puik, et al.
Published: (2025-01-01)

The Potential of TRPA1 as a Therapeutic Target in Cancer—A Study Using Bioinformatic Tools
by: Dana Cucu
Published: (2024-12-01)

Prolonged survival by combination treatment with a standardized herbal extract from Japanese Kampo-medicine (Juzentaihoto) and gemcitabine in an orthotopic transplantation pancreatic cancer model
by: Joanna Napp, et al.
Published: (2024-12-01)

Commentary: An insight to PDAC tumor heterogeneity across pancreatic subregions using computed tomography images
by: Jiandong Cao, et al.
Published: (2025-04-01)

Genetics and clinical implications of SPINK1 in the pancreatitis continuum and pancreatic cancer
by: Qi-Wen Wang, et al.
Published: (2025-03-01)

Obesity reprograms the normal pancreas and pancreatic cancer microbiome in mice and humans
by: Raquel Santana da Cruz, et al.
Published: (2025-07-01)

The polymeric fluoropyrimidine CF10 overcomes limitations of 5-FU in pancreatic ductal adenocarcinoma cells through increased replication stress
by: Jennifer M. Finan, et al.
Published: (2024-12-01)

Innovative Approaches in the Treatment of Pancreatic Cancer: The Role of CAR T-Cell Therapy
by: Jakub Kuźniar, et al.
Published: (2025-05-01)

Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis
by: Yuan Fang, et al.
Published: (2024-11-01)

KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma
by: Mahmoud Yousef, et al.
Published: (2025-04-01)

Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial
by: Michael Ghadimi, et al.
Published: (2025-02-01)

An interpretable machine learning model for predicting early liver metastasis after pancreatic cancer surgery
by: Hao Zhu, et al.
Published: (2025-07-01)

Most oncological pancreas resections must consider the mesopancreas
by: S. A. Safi, et al.
Published: (2025-02-01)

Upregulation of Lactobacillus spp. in gut microbiota as a novel mechanism for environmental eustress-induced anti-pancreatic cancer effects
by: Yiyi Liang, et al.
Published: (2025-12-01)

Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC)
by: Han Yin, et al.
Published: (2024-08-01)

Abnormalities in T cell subsets in the circulating immunity and tumor microenvironment in patients with pancreatic ductal adenocarcinoma
by: SU Bingwei, SHEN Baiyong
Published: (2025-03-01)

Can AI Be Useful in the Early Detection of Pancreatic Cancer in Patients with New-Onset Diabetes?
by: Maja Mejza, et al.
Published: (2025-03-01)

Mechanistic insights and therapeutic strategies for targeting autophagy in pancreatic ductal adenocarcinoma
by: Federica Michetti, et al.
Published: (2025-04-01)

Elevated KRAS protein level is associated with better survival in pancreatic cancer
by: S. M. Stålberg, et al.
Published: (2025-07-01)

A sex dependent association between the history of autoimmune disease and the development of pancreatic cancer: a case-control study of 32,640 patients
by: Sven H. Loosen, et al.
Published: (2025-07-01)

Radiotherapy and immune microenvironment crosstalk in pancreatic cancer: a comprehensive review of current insights and future directions
by: Yucheng Xu, et al.
Published: (2025-07-01)

Efficacy of CRISPR-Cas9 gene editing for targeting KRAS mutations in pancreatic cancer: a systematic review
by: Hashim Talib Hashim, et al.
Published: (2025-04-01)

Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenocarcinoma
by: Dimitrios Papakonstantinou, et al.
Published: (2025-01-01)

Modified Altemeier Procedure as Management for Incarcerated Rectal Prolapse in a Young Healthy Male Patient: A Case Report and Literature Review
by: Leenah Abdulgader, et al.
Published: (2024-11-01)

Targeting FGFR4 abrogates HNF1A-driven metastasis in pancreatic ductal adenocarcinoma
by: Katherine J. Crawford, et al.
Published: (2025-07-01)

Combining molecular characteristics and therapeutic analysis of PDOs predict clinical responses and guide PDAC personalized treatment
by: Peng Li, et al.
Published: (2025-02-01)

Development of a Machine‐Learning Model for Diagnosis of Pancreatic Cancer from Serum Samples Analyzed by Thermal Liquid Biopsy
by: Sonia Hermoso‐Durán, et al.
Published: (2025-01-01)

A High-Affinity Monoclonal Antibody Against the Pancreatic Ductal Adenocarcinoma Target, Anterior Gradient-2 (AGR2/PDIA17)
by: Reeder M. Robinson, et al.
Published: (2024-12-01)

Intra-tumoral administration of CHST15 siRNA remodels tumor microenvironment and augments tumor-infiltrating T cells in pancreatic cancer
by: Juanjuan Ye, et al.
Published: (2024-06-01)

PLAGL2 as a prognostic biomarker and an EMT-promoting factor in PDAC
by: Yan-Hui Yang, et al.
Published: (2025-07-01)

The comparison of IGFBP-5 expression level in Pancreatic ductal adenocarcinoma tumors and their normal adjacent tissues
by: Jafar Karim Ghate, et al.
Published: (2025-06-01)

Weighted gene co-expression network analysis reveals key stromal prognostic markers in pancreatic cancer
by: G. Mantini, et al.
Published: (2024-12-01)

Development and validation of a CT-measured body composition radiomics model for prognostic assessment in resected pancreatic adenocarcinoma
by: Qianbiao Gu, et al.
Published: (2025-08-01)

Immune checkpoint inhibitors in pancreatic adenocarcinoma: a systematic review and meta analysis of clinical outcomes
by: Aisha Al-Khinji, et al.
Published: (2025-08-01)